October 23, 2018  Print

The Peter Castaldi Memorial Symposium celebrates Peter’s life of achievements and his significant contribution to research excellence at Westmead.

The Peter Castaldi Memorial Symposium celebrates Peter’s life of achievements and his significant contribution to research excellence at Westmead.

Professor Castaldi was the initial driving force behind the research excellence of Westmead Hospital, from which the Westmead Institute for Medical Research developed. Together with Miles Little, he laid down the guiding principles for Westmead Hospital, based on a vision, humanity, clinical skills and commitment to academic excellence through teaching and research.

Peter’s son, Julien Castaldi, will lead a panel conversation with a new generation of esteemed researchers about how Peter’s legacy lives on in Westmead today, and how it inspires their innovative translational research which is transforming lives.

Panel members include:

Professor Jon Iredell, who is using bacteriophage to cure patients infected by bacteria and ‘superbugs’ that are resistant to antibiotics.

 

 

Professor Anna deFazio, who is working to deliver personalised treatments for women with ovarian cancer.

 

 

Professor Clara Chow, who is committed to reducing the burden of cardiovascular disease through prevention and innovative approaches to treat the disease.

 

 

Dr Ken Micklethwaite, who is developing new cell therapies to treat people with leukaemia and lymphoma.

 

 

Professor Miles Little will introduce the Peter Castaldi Memorial Symposium and speak about Peter, his contribution to Westmead and his legacy. Professor Stephen Garton, Provost and Deputy Vice-Chancellor of the University of Sydney, will make closing remarks.

Drinks and canapés will be served following the panel discussion.
 

Event details:

Date: Tuesday 6 November 2018

Time: 4:00 pm – 5:00 pm AEDT

Venue: The Westmead Institute for Medical Research

176 Hawkesbury Road

Westmead, NSW 2145

RSVP: Via Eventbrite. Please RSVP by Tuesday 30 October.